In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Foghorn Therapeutics (FHTX – Research Report), with a ...

Objective clinical responses by standard response criteria observed in Phase 1 dose escalation trial for FHD-286 in combination with decitabine ...

Explore the latest company news, creator and artist profiles, culture and trends analyses, and behind-the-scenes insights on the YouTube Official Blog.